ESMO 2012: Bevacizumab for first and second-line beyond progression in colorectal cancer - 101480

Spotlight
Video

ESMO 2012: Bevacizumab for first and second-line beyond progression in colorectal cancer

ESMO has 24 videos Subscribe Here

Loading........
Description: Jean-Yves Douillard explores the BEBYP academic trial and highlights differences to previous studies while highlighting new promises for this group of patients. This trial was presented during ESMO 2012, the Congress of the European Society for Medical Oncology. Read all the news about the latest in cancer and oncology from the Congress here http://www.esmo.org/events/...

The opinion expressed in this interview reflects that of the interviewee and does not necessarily express the official ESMO point of view.

http://www.esmo.org...
Video produced by the European Society for Medical Oncology (ESMO)
Access all the ESMO scientific video resources: http://www.youtube.com/ESMO...
Shared By : ESMO
Posted on : 10/04/12
Added : 7 years ago
Category : News